vs

Side-by-side financial comparison of INTERNATIONAL BANCSHARES CORP (IBOC) and LifeStance Health Group, Inc. (LFST). Click either name above to swap in a different company.

LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $217.7M, roughly 1.8× INTERNATIONAL BANCSHARES CORP). INTERNATIONAL BANCSHARES CORP runs the higher net margin — 62.3% vs 3.1%, a 59.3% gap on every dollar of revenue. On growth, LifeStance Health Group, Inc. posted the faster year-over-year revenue change (17.4% vs 4.5%). INTERNATIONAL BANCSHARES CORP produced more free cash flow last quarter ($472.9M vs $46.6M). Over the past eight quarters, LifeStance Health Group, Inc.'s revenue compounded faster (12.8% CAGR vs 2.8%).

International Bancshares Corporation is a bank holding company based in Laredo, Texas whose primary subsidiary is International Bank of Commerce. Through its bank subsidiaries, it has 217 banking offices and 315 automated teller machines serving 88 communities in the U.S. states of Texas and Oklahoma.

Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.

IBOC vs LFST — Head-to-Head

Bigger by revenue
LFST
LFST
1.8× larger
LFST
$382.2M
$217.7M
IBOC
Growing faster (revenue YoY)
LFST
LFST
+12.9% gap
LFST
17.4%
4.5%
IBOC
Higher net margin
IBOC
IBOC
59.3% more per $
IBOC
62.3%
3.1%
LFST
More free cash flow
IBOC
IBOC
$426.3M more FCF
IBOC
$472.9M
$46.6M
LFST
Faster 2-yr revenue CAGR
LFST
LFST
Annualised
LFST
12.8%
2.8%
IBOC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IBOC
IBOC
LFST
LFST
Revenue
$217.7M
$382.2M
Net Profit
$106.9M
$11.7M
Gross Margin
Operating Margin
62.8%
4.7%
Net Margin
62.3%
3.1%
Revenue YoY
4.5%
17.4%
Net Profit YoY
-7.1%
264.1%
EPS (diluted)
$1.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBOC
IBOC
LFST
LFST
Q4 25
$217.7M
$382.2M
Q3 25
$218.1M
$363.8M
Q2 25
$208.2M
$345.3M
Q1 25
$198.2M
$333.0M
Q4 24
$208.3M
$325.5M
Q3 24
$211.8M
$312.7M
Q2 24
$207.8M
$312.3M
Q1 24
$205.8M
$300.4M
Net Profit
IBOC
IBOC
LFST
LFST
Q4 25
$106.9M
$11.7M
Q3 25
$108.4M
$1.1M
Q2 25
$100.1M
$-3.8M
Q1 25
$96.9M
$709.0K
Q4 24
$115.1M
$-7.1M
Q3 24
$99.8M
$-6.0M
Q2 24
$97.0M
$-23.3M
Q1 24
$97.3M
$-21.1M
Operating Margin
IBOC
IBOC
LFST
LFST
Q4 25
62.8%
4.7%
Q3 25
62.6%
2.0%
Q2 25
60.5%
-0.9%
Q1 25
61.1%
0.5%
Q4 24
64.2%
0.3%
Q3 24
60.0%
0.0%
Q2 24
60.1%
-5.1%
Q1 24
59.9%
-5.6%
Net Margin
IBOC
IBOC
LFST
LFST
Q4 25
62.3%
3.1%
Q3 25
49.7%
0.3%
Q2 25
48.1%
-1.1%
Q1 25
48.9%
0.2%
Q4 24
71.5%
-2.2%
Q3 24
47.1%
-1.9%
Q2 24
46.7%
-7.5%
Q1 24
47.3%
-7.0%
EPS (diluted)
IBOC
IBOC
LFST
LFST
Q4 25
$1.71
Q3 25
$1.74
Q2 25
$1.61
Q1 25
$1.56
Q4 24
$1.85
Q3 24
$1.60
Q2 24
$1.56
Q1 24
$1.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBOC
IBOC
LFST
LFST
Cash + ST InvestmentsLiquidity on hand
$5.5B
$248.6M
Total DebtLower is stronger
$282.8M
Stockholders' EquityBook value
$3.3B
$1.5B
Total Assets
$16.6B
$2.2B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBOC
IBOC
LFST
LFST
Q4 25
$5.5B
$248.6M
Q3 25
$5.6B
$203.9M
Q2 25
$5.8B
$188.9M
Q1 25
$5.6B
$134.3M
Q4 24
$5.4B
$154.6M
Q3 24
$5.8B
$102.6M
Q2 24
$5.7B
$87.0M
Q1 24
$5.7B
$49.5M
Total Debt
IBOC
IBOC
LFST
LFST
Q4 25
$282.8M
Q3 25
$284.6M
Q2 25
$286.4M
Q1 25
$288.2M
Q4 24
$290.0M
Q3 24
$287.3M
Q2 24
$288.0M
Q1 24
$288.8M
Stockholders' Equity
IBOC
IBOC
LFST
LFST
Q4 25
$3.3B
$1.5B
Q3 25
$3.1B
$1.5B
Q2 25
$3.0B
$1.5B
Q1 25
$2.9B
$1.5B
Q4 24
$2.8B
$1.4B
Q3 24
$2.7B
$1.4B
Q2 24
$2.6B
$1.4B
Q1 24
$2.5B
$1.4B
Total Assets
IBOC
IBOC
LFST
LFST
Q4 25
$16.6B
$2.2B
Q3 25
$16.6B
$2.1B
Q2 25
$16.5B
$2.1B
Q1 25
$16.3B
$2.1B
Q4 24
$15.7B
$2.1B
Q3 24
$15.9B
$2.1B
Q2 24
$15.5B
$2.1B
Q1 24
$15.4B
$2.1B
Debt / Equity
IBOC
IBOC
LFST
LFST
Q4 25
0.19×
Q3 25
0.19×
Q2 25
0.19×
Q1 25
0.20×
Q4 24
0.20×
Q3 24
0.20×
Q2 24
0.20×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBOC
IBOC
LFST
LFST
Operating Cash FlowLast quarter
$491.1M
$57.6M
Free Cash FlowOCF − Capex
$472.9M
$46.6M
FCF MarginFCF / Revenue
217.2%
12.2%
Capex IntensityCapex / Revenue
8.3%
2.9%
Cash ConversionOCF / Net Profit
4.59×
4.93×
TTM Free Cash FlowTrailing 4 quarters
$809.9M
$110.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBOC
IBOC
LFST
LFST
Q4 25
$491.1M
$57.6M
Q3 25
$115.2M
$27.3M
Q2 25
$95.5M
$64.4M
Q1 25
$140.5M
$-3.1M
Q4 24
$473.9M
$62.3M
Q3 24
$116.5M
$22.7M
Q2 24
$107.2M
$44.1M
Q1 24
$135.4M
$-21.8M
Free Cash Flow
IBOC
IBOC
LFST
LFST
Q4 25
$472.9M
$46.6M
Q3 25
$112.2M
$17.0M
Q2 25
$91.6M
$56.6M
Q1 25
$133.1M
$-10.3M
Q4 24
$459.8M
$56.0M
Q3 24
$109.6M
$17.7M
Q2 24
$104.9M
$39.0M
Q1 24
$128.9M
$-26.9M
FCF Margin
IBOC
IBOC
LFST
LFST
Q4 25
217.2%
12.2%
Q3 25
51.5%
4.7%
Q2 25
44.0%
16.4%
Q1 25
67.1%
-3.1%
Q4 24
220.8%
17.2%
Q3 24
51.7%
5.7%
Q2 24
50.5%
12.5%
Q1 24
62.6%
-9.0%
Capex Intensity
IBOC
IBOC
LFST
LFST
Q4 25
8.3%
2.9%
Q3 25
1.3%
2.8%
Q2 25
1.9%
2.2%
Q1 25
3.7%
2.2%
Q4 24
6.8%
1.9%
Q3 24
3.3%
1.6%
Q2 24
1.1%
1.6%
Q1 24
3.2%
1.7%
Cash Conversion
IBOC
IBOC
LFST
LFST
Q4 25
4.59×
4.93×
Q3 25
1.06×
25.34×
Q2 25
0.95×
Q1 25
1.45×
-4.36×
Q4 24
4.12×
Q3 24
1.17×
Q2 24
1.11×
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons